Alafi Christopher D

Track

Insider profile

Performance

Overall performance
2.8
Performance over holding periods
2.8
30 days 90 days 120 days
Average return -14% 8.2% 15.1%
Success rate 13% 68% 82%
Transactions
11 100% Buy
34 71% Buy
47 69% Buy
Ranking by holding-period performance
Alafi Christopher D's trades of Intra-Cellular Therapies Inc's stock


• Purchase • Sale • Planned purchase • Planned sale Net purchase Net sale Buy signal Sell signal Earnings
Abbreviations B: Buy, S: Sell, PP: Planned purchase, PlS: Planned sale, PrS: Proposed sale, O: Option / Other
Notification date Transaction date Company B/S Transaction type Nb. shares
Price
Value 		Number of shares Price Value Details
2021-05-28 2021-05-28
PlS Planned sale
59,427 +17.8%
426.18
US$2,866,506 		59,427 +17.8% 426.18 US$2,866,506
2021-05-28 2021-05-27
PlS Planned sale
53,100 +34.8%
219.28
US$175,938 		53,100 +34.8% 219.28 US$175,938
2020-09-14 2020-09-14
B Purchase
12,893 -8.1%
278.01
US$4,987,080 		12,893 -8.1% 278.01 US$4,987,080
2020-09-11 2020-09-11
B Purchase
21,000 +0.4%
28.08
US$589,680 		21,000 +0.4% 28.08 US$589,680
2019-09-11 2019-09-10
B Purchase
6,240 +0.1%
11.00
US$68,640 		6,240 +0.1% 11.00 US$68,640
2019-09-11 2019-09-10
B Purchase
320,095 +7.4%
10.58
US$3,386,605 		320,095 +7.4% 10.58 US$3,386,605
2019-09-11 2019-09-10
B Purchase
155,116 +3.7%
9.59
US$1,487,562 		155,116 +3.7% 9.59 US$1,487,562
2019-09-11 2019-09-10
B Purchase
3,549 +0.1%
8.98
US$31,870 		3,549 +0.1% 8.98 US$31,870
2019-09-04 2019-08-30
B Purchase
125,000 +3.1%
8.52
US$1,065,212 		125,000 +3.1% 8.52 US$1,065,212
2019-06-14 2019-06-12
B Purchase
58,705 +52.7%
12.00
US$704,460 		58,705 +52.7% 12.00 US$704,460
2019-06-14 2019-06-12
B Purchase
95,069 +585.9%
11.70
US$1,112,307 		95,069 +585.9% 11.70 US$1,112,307
2019-06-14 2019-06-12
B Purchase
16,226 +inf%
10.91
US$177,026 		16,226 +inf% 10.91 US$177,026
2019-05-15 2019-05-14
B Purchase
100,000 +2.5%
12.56
US$1,256,350 		100,000 +2.5% 12.56 US$1,256,350